-
Amazon Deals - ToS - Like us?
Health & Medical News
- Thread starter saarth
- Start date
- Replies 681
- Views 46,599
India approves its first dengue vaccine QDENGA after DCGI clearance
NEW DELHI: India has approved its first dengue vaccine, with the Drug Controller General of India (DCGI) granting market authorisation to vaccine QDENGA, developed by Takeda Biopharmaceuticals India.
timesofindia.indiatimes.com
Delhi High Court refuses to stay administration of HPV vaccine after Centre assures it is safe
The Delhi High Court on Wednesday refused to stay the administration of the Human Papillomavirus (HPV) vaccine, Gardasil, to adolescent girls. A bench of Chief
Why Maharashtra's CCMP policy has sparked a debate over BHMS, MBBS and medical qualifications
Maharashtra CCMP: The Maharashtra government's recent decision to allow BHMS graduates completing the CCMP to register with the medical council has ignited protests from resident doctors and raised questions about medical qualifications in India. A debate unfolds over the legitimacy of...
education.economictimes.indiatimes.com
The air Delhi's TB patients breathe may be shaping their chances of survival, study shows
New Delhi, Aug 6 (PTI) A large epidemiological study has found a possible link between exposure to fine particulate air pollution (PM2.5) and a higher risk of death among tuberculosis patients undergoing treatment in Delhi. The study accessed by PTI, and described by researchers as the world’s...
theprint.in
Recce in govt hospitals, illegal IVF route: How women gang ran child trafficking racket
North Delhi police busted a child trafficking racket: five women allegedly targeted vulnerable mothers in govt hospitals and via illegal IVF surrogacy, selling newborns.
timesofindia.indiatimes.com
More than 1,700 swine flu cases logged in Delhi this year amid surge in seasonal influenza infections
Delhi reports over 1,700 swine flu cases amid rising flu infections, prompting government action for adequate healthcare facilities.
Many TB prescriptions outside national programme do not follow treatment guidelines, study finds
A study reveals over 53% of anti-TB prescriptions outside India's national program are faulty, risking treatment effectiveness.
